Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

OBJECTIVES: In some patients the immune response triggered by SARS-CoV-2 is unbalanced, presenting an acute respiratory distress syndrome which in many cases requires intensive care unit (ICU) admission. The limitation of ICU beds has been one of the major burdens in the management around the world;...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rev Esp Quimioter
Main Authors: Moreno-García, Estela, Rico, Verónica, Albiach, Laia, Agüero, Daiana, Ambrosioni, Juan, Bodro, Marta, Cardozo, Celia, Chumbita, Mariana, De la Mora, Lorena, García-Pouton, Nicole, Garcia-Vidal, Carolina, González-Cordón, Ana, Hernández-Meneses, Marta, Inciarte, Alexy, Laguno, Montse, Leal, Lorna, Linares, Laura, Macaya, Irene, Meira, Fernanda, Mensa, Josep, Moreno, Antonio, Morata, Laura, Puerta-Alcalde, Pedro, Rojas, Jhon, Solá, Montse, Torres, Berta, Torres, Manuel, Tomé, Adrià, Tuset, Montse, Castro, Pedro, Fernández, Sara, Nicolás, Josep Maria, Almuedo-Riera, Alex, Muñoz, Jose, Fernandez-Pittol, Mariana, Marcos, Maria Angeles, Soy, Dolors, Martínez, José Antonio, García, Felipe, Soriano, Alex
Formato: Artigo
Idioma:Inglês
Publicado em: Sociedad Española de Quimioterapia 2021
Assuntos:
Original
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8179941/
https://ncbi.nlm.nih.gov/pubmed/33829722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.37201/req/037.2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados